Celldex Therapeutics (CLDX) Receivables - Accured (2013 - 2026)
Celldex Therapeutics' Receivables - Accured came in at $6.3 million for Q2 2026, up 1.6% from $6.2 million a year earlier and up 34.0% from the prior quarter.
Powered by 
Analysis
Celldex Therapeutics (CLDX) Receivables - Accured (2013 - 2026) Analysis & Trends
At the end of FY2025, Celldex Therapeutics' Receivables - Accured was $4.4 million, down 27.9% from FY2024.
- Receivables - Accured carries a five-year compound annual growth rate of 85.6% (FY2020 to FY2025).
- Going back by year, Receivables - Accured was $6.1 million in FY2024 (+221.1%), $1.9 million in FY2023 (+137.5%), $800,000 in FY2022 (-38.5%) and $1.3 million in FY2021 (+550.0%).
- The Q2 2026 figure represents the highest quarterly Receivables - Accured in data going back to Q4 2013.
- Year-over-year, Receivables - Accured increased in six of the last eight quarters, with growth averaging 73.1%.
- The fastest year-over-year change in Receivables - Accured over five years came in Q1 2024 (growth of 683.3%), and the weakest in Q4 2022 (a decline of 38.5%).
- Business Quant data shows CLDX's Receivables - Accured at $4.7 million (Q1 2026), $4.4 million (Q4 2025) and $6 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables - Accured (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | - |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | - |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | - |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | Celldex Therapeutics | 2.47 Bn | 2.47 Bn | - | 6.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.30 Mn |
| Mar 31, 2026 | 4.70 Mn |
| Dec 31, 2025 | 4.40 Mn |
| Sep 30, 2025 | 6.00 Mn |
| Jun 30, 2025 | 6.20 Mn |
| Mar 31, 2025 | 6.00 Mn |
| Dec 31, 2024 | 6.10 Mn |
| Sep 30, 2024 | 5.30 Mn |
| Jun 30, 2024 | 4.80 Mn |
| Mar 31, 2024 | 4.70 Mn |
| Dec 31, 2023 | 1.90 Mn |
| Sep 30, 2023 | 1.20 Mn |
| Jun 30, 2023 | 1.30 Mn |
| Mar 31, 2023 | 600,000.00 |
| Dec 31, 2022 | 800,000.00 |
| Sep 30, 2022 | 700,000.00 |
| Jun 30, 2022 | 1.10 Mn |
| Mar 31, 2022 | 800,000.00 |
| Dec 31, 2021 | 1.30 Mn |
| Sep 30, 2021 | 800,000.00 |
API Access
Celldex Therapeutics Receivables - Accured API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-accured&ticker=CLDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-accured", "ticker": "CLDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-accured&ticker=CLDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();